Video: Sharing experience with industry partners
Dr Paul Huang leads our Molecular and Systems Oncology Team, located within the Division of Molecular Pathology.
The team seeks to understand how networks of signalling proteins control tumour progression and drug resistance in cancer, and identifies drugs that could overcome this resistance in patients.
This work brings together information from biochemistry, computational modelling, molecular pathology and proteomics.
Dr Huang is keen to collaborate with industry partners on a number of projects.
In particular, the team has significant experience in identifying biomarkers of patient benefit, and in patient stratification, which they are keen to share with commercial partners.
These partners could include providers of companion diagnostics and pharmaceutical companies who want to develop new biomarkers for their drugs.
Watch more videos of our researchers
Working with pharmaceutical companies
Dr Marco Gerlinger's Translational Oncogenomics Team are keen to develop new partnerships to continue their work, and to access drugs that could reverse the resistance mechanisms that the team has identified so far.
New partnerships in cancer epigenetics
Sharing experience with industry partners
Our Molecular and Systems Oncology Team, led by Dr Paul Huang, is keen to collaborate with industry partners on a number of projects on biochemistry, computational modelling, molecular pathology and proteomics.
Collaborating with commercial partners
Our Systems and Precision Cancer Medicine team, led by Dr Anguraj Sadanandam, is investigating ways to stratify tumours based on their genetic and clinical diversity.
The benefits of partnering with industry
Our Molecular Addictions team, led by Dr Igor Vivanco, is working on a variety of projects that could be developed in collaboration with commercial partners.
Exploring new opportunities for collaborative working
Professor Uwe Oelfke, Deputy Head of the Division of Radiotherapy and Imaging, is keen to explore new opportunities for collaborative working with industry.